Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
Polaryx Therapeutics (PLYX) has been named a Diamond honoree at the 2026 Pinnacle Awards for Healthcare for its work in developing therapies for rare pediatric lysosomal storage disorders. The company's approach focuses on targeting shared biological mechanisms to improve treatment efficiency. The recognition highlights its innovative platform and contributions to pediatric care.
Tickers: $PLYX
Topics: Awards Biotechnology Healthcare Pediatric Care